recent articles
Lumea and Valar Labs today announced a partnership to integrate Valar Labs' Vesta tests into the Lumea digital pathology platform. LEHI, UT, UNITED STATES, October 9, 2025 /EINPresswire.com/ -- Lumea, the U.S. leader in primary clinical...
The latest from the Proscia blog: Every diagnosis is based on data that can change the course of drug development and patient care. With the growing adoption of digital pathology, laboratories are now generating a wealth of tissue images...
Proscia Apeature enables biopharmaceutical companies to accelerate precision drug development by delivering real-time patient insights from a global laboratory network on track to diagnose 8 million pathology cases annually. Opens new...
Paige Collaborates with Microsoft to Transform Cancer Diagnosis and Treatment with the Use of Pathology AI Companies to lead digital transformation of pathology and cancer diagnosis NEW YORK--(BUSINESS WIRE)--Paige announced a...
Over the summer a longtime friend asked if I could review some slides for a friend of his, or actually from his friend’s wife. Of course I agreed to do so. He mentioned that she had “metastatic breast cancer” and wanted to make sure the...